Kopp, M. V.
3 papers on CoChatORCID 0000-0003-1989-5492
Most cited papers
- Verified
Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co‐morbid seasonal allergic asthma
Kopp, M. V., Hamelmann, E., Zielen, S., Kamin, W., Bergmann, K. ‐., Sieder, C., Stenglein, S., Seyfried, S., Wahn, U., & for the DUAL study group (2009) · Clinical & Experimental Allergy
Allergic Rhinitis and SensitizationAsthma and respiratory diseases
Cited by 181
- Verified
The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis
Kopp, M. V., Brauburger, J., Riedinger, F., Beischer a, D., Ihorst, G., Kamin, W., Zielen, S., Bez, C., Friedrichs, F., von Berg, A., et al. (2002) · Journal of Allergy and Clinical Immunology
Allergic Rhinitis and SensitizationAsthma and respiratory diseases
Cited by 84
- Verified
Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: A multicentre, open-label, randomised trial
Ballmann, M., Hubert, D., Assael, B. M., Staab, D., Hebestreit, A., Naehrlich, L., Nickolay, T., Prinz, N., Holl, R. W., Staden, U., et al. (2018) · The Lancet Diabetes & Endocrinology
Cystic Fibrosis Research AdvancesDiabetes Treatment and Management
Cited by 71
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free